NHSWYICB - Neurodevelopmental Assessment Service (Window 2)

The NHS West Yorkshire Integrated Care Board (NHS WY ICB) has been actively engaged in procuring contracts for Neurodevelopmental Assessment Services under the Provider Selection Regime, governed by Health Care Services (Provider Selection Regime) Regulations 2023. This public procurement process falls under the health services category and aims to provide assessments and treatments related to ASD and ADHD in West Yorkshire. Notably, this process includes several windows for service delivery, with contracts for subsequent windows having been confirmed in 2025.

The procurement method applied is the open procedure, ensuring transparency and accessibility for qualified providers. The contract terms span from July 2025 to June 2027, with a focus on patient choice as the essential quality criterion rather than price. This tender process presents significant business growth opportunities for health service providers specialising in neurodevelopmental conditions.

Providers equipped to deliver comprehensive diagnostic assessments and ADHD medication will be well-suited to participate. Furthermore, organisations that demonstrate an ability to ensure high-quality, clinically appropriate, and cost-effective care can benefit greatly. As contracts are awarded through Direct Award Process B to all providers meeting service delivery requirements, small and medium-sized enterprises, in particular, can seize this opportunity to expand their client base and enhance their operational scope in West Yorkshire.

Providers such as Innovate ADHD LTD and Mantle Psychology Ltd have already been involved, highlighting the potential for diverse health service entities to engage in this sector.